Viatris Analyst Ratings
Viatris Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/23/2023 | -0.33% | B of A Securities | → $9 | Downgrades | Neutral → Underperform |
| 06/23/2023 | 21.82% | Barclays | → $11 | Downgrades | Equal-Weight → Underweight |
| 04/25/2023 | 21.82% | Barclays | $16 → $11 | Downgrades | Overweight → Equal-Weight |
| 04/24/2023 | 21.82% | Barclays | → $11 | Downgrades | Overweight → Equal-Weight |
| 02/28/2023 | 77.19% | Barclays | $15 → $16 | Maintains | Overweight |
| 02/17/2023 | 55.04% | BMO Capital | $16 → $14 | Downgrades | Outperform → Market Perform |
| 02/01/2023 | 66.11% | Barclays | $16 → $15 | Maintains | Overweight |
| 01/27/2023 | 66.11% | Jefferies | $13 → $15 | Upgrades | Hold → Buy |
| 11/15/2022 | 55.04% | JP Morgan | $13 → $14 | Maintains | Neutral |
| 11/10/2022 | 32.89% | UBS | $9 → $12 | Upgrades | Sell → Neutral |
| 11/08/2022 | 10.74% | Piper Sandler | → $10 | Upgrades | Underweight → Neutral |
| 10/25/2022 | 77.19% | Barclays | $21 → $16 | Maintains | Overweight |
| 10/21/2022 | 21.82% | Jefferies | → $11 | Initiates Coverage On | → Hold |
| 08/09/2022 | 77.19% | BMO Capital | $19 → $16 | Maintains | Outperform |
| 06/14/2022 | -0.33% | UBS | → $9 | Initiates Coverage On | → Sell |
| 05/12/2022 | 21.82% | Goldman Sachs | $10 → $11 | Maintains | Neutral |
| 05/10/2022 | 10.74% | Piper Sandler | → $10 | Downgrades | Neutral → Underweight |
| 03/16/2022 | 10.74% | Piper Sandler | $17 → $10 | Maintains | Neutral |
| 03/10/2022 | 21.82% | Citigroup | $16 → $11 | Maintains | Neutral |
| 03/01/2022 | 43.96% | B of A Securities | $21 → $13 | Downgrades | Buy → Neutral |
| 03/01/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 06/15/2021 | 77.19% | Citigroup | → $16 | Initiates Coverage On | → Neutral |
| 03/10/2021 | 77.19% | Morgan Stanley | $18 → $16 | Maintains | Equal-Weight |
| 03/08/2021 | 66.11% | Goldman Sachs | $20 → $15 | Downgrades | Buy → Neutral |
| 03/02/2021 | 99.34% | JP Morgan | → $18 | Downgrades | Overweight → Neutral |
| 02/23/2021 | 110.41% | Raymond James | $23 → $19 | Maintains | Outperform |
| 01/25/2021 | 154.71% | Raymond James | $27 → $23 | Maintains | Outperform |
| 01/05/2021 | — | Argus Research | Initiates Coverage On | → Hold | |
| 12/14/2020 | 132.56% | Bernstein | → $21 | Initiates Coverage On | → Market Perform |
| 11/19/2020 | 143.63% | Goldman Sachs | → $22 | Reinstates | → Buy |
| 11/18/2020 | — | Edward Jones | Initiates Coverage On | → Sell |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/23/2023 | -0.33% | B of A证券 | →$9 | 评级下调 | 中性→表现不佳 |
| 2023/06/23 | 21.82% | 巴克莱 | →$11 | 评级下调 | 等重→减码 |
| 04/25/2023 | 21.82% | 巴克莱 | $16→$11 | 评级下调 | 超重→等重 |
| 04/24/2023 | 21.82% | 巴克莱 | →$11 | 评级下调 | 超重→等重 |
| 02/28/2023 | 77.19% | 巴克莱 | $15→$16 | 维护 | 超重 |
| 02/17/2023 | 55.04% | 蒙特利尔银行资本 | $16→$14 | 评级下调 | 跑赢→市场表现 |
| 02/01/2023 | 66.11% | 巴克莱 | $16→$15 | 维护 | 超重 |
| 2023年1月27日 | 66.11% | 杰富瑞 | $13→$15 | 升级 | 持有→购买 |
| 2022年11月15日 | 55.04% | 摩根大通 | $13→$14 | 维护 | 中性 |
| 2022年11月10日 | 32.89% | 瑞银集团 | $9→$12 | 升级 | 卖出→中性 |
| 11/08/2022 | 10.74% | 派珀·桑德勒 | →$10 | 升级 | 减重→中性 |
| 2022年10月25日 | 77.19% | 巴克莱 | $21→$16 | 维护 | 超重 |
| 2022年10月21日 | 21.82% | 杰富瑞 | →$11 | 开始承保 | →保留 |
| 08/09/2022 | 77.19% | 蒙特利尔银行资本 | $19→$16 | 维护 | 跑赢大盘 |
| 2022/06/14 | -0.33% | 瑞银集团 | →$9 | 开始承保 | →销售 |
| 2022年05月12日 | 21.82% | 高盛 | $10→$11 | 维护 | 中性 |
| 2022年05月10日 | 10.74% | 派珀·桑德勒 | →$10 | 评级下调 | 中性→减持 |
| 03/16/2022 | 10.74% | 派珀·桑德勒 | $17→$10 | 维护 | 中性 |
| 03/10/2022 | 21.82% | 花旗集团 | $16→$11 | 维护 | 中性 |
| 03/01/2022 | 43.96% | B of A证券 | $21→$13 | 评级下调 | 购买→中性 |
| 03/01/2022 | - | 雷蒙德·詹姆斯 | 评级下调 | 跑赢→市场表现 | |
| 2021/06/15 | 77.19% | 花旗集团 | →$16 | 开始承保 | →中性 |
| 03/10/2021 | 77.19% | 摩根士丹利 | $18→$16 | 维护 | 等重 |
| 03/08/2021 | 66.11% | 高盛 | $20→$15 | 评级下调 | 购买→中性 |
| 03/02/2021 | 99.34% | 摩根大通 | →$18 | 评级下调 | 超重→中性 |
| 02/23/2021 | 110.41% | 雷蒙德·詹姆斯 | $23→$19 | 维护 | 跑赢大盘 |
| 2021/01/25 | 154.71% | 雷蒙德·詹姆斯 | $27→$23 | 维护 | 跑赢大盘 |
| 01/05/2021 | - | Argus研究 | 开始承保 | →保留 | |
| 12/14/2020 | 132.56% | 伯恩斯坦 | →$21 | 开始承保 | →市场表现 |
| 11/19/2020 | 143.63% | 高盛 | →$22 | 恢复 | →购买 |
| 11/18/2020 | - | 爱德华·琼斯 | 开始承保 | →销售 |
What is the target price for Viatris (VTRS)?
Viatris(录像机)的目标价格是多少？
The latest price target for Viatris (NASDAQ: VTRS) was reported by B of A Securities on October 23, 2023. The analyst firm set a price target for $9.00 expecting VTRS to fall to within 12 months (a possible -0.33% downside). 12 analyst firms have reported ratings in the last year.
美国银行证券于2023年10月23日报告了Viatris(纳斯达克：VTRS)的最新目标价。这家分析公司将目标价定为9美元，预计VRR将在12个月内降至(可能下跌-0.33%)。去年有12家分析公司公布了评级。
What is the most recent analyst rating for Viatris (VTRS)?
Viatris(VRR)的最新分析师评级是多少？
The latest analyst rating for Viatris (NASDAQ: VTRS) was provided by B of A Securities, and Viatris downgraded their underperform rating.
维亚特里斯(纳斯达克代码：VTRS)的最新分析师评级是由美国银行证券提供的，维亚特里斯下调了其表现不佳的评级。
When is the next analyst rating going to be posted or updated for Viatris (VTRS)?
Viatris(VRR)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viatris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viatris was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Viatris的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Viatris的上一次评级是在2023年10月23日提交的，因此您应该预计下一次评级将在2024年10月23日左右提供。
Is the Analyst Rating Viatris (VTRS) correct?
分析师对Viatris(VTRs)的评级正确吗？
While ratings are subjective and will change, the latest Viatris (VTRS) rating was a downgraded with a price target of $0.00 to $9.00. The current price Viatris (VTRS) is trading at is $9.03, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Viatris(VTRS)评级被下调，目标价为0.00美元至9.00美元。Viatris目前的交易价格为9.03美元，超出了分析师的预测区间。